Literature DB >> 16113312

Quantitative assessment of protection in experimental syphilis.

Cheryl I Champion1, David R Blanco, Michael A Lovett.   

Abstract

Protection in experimental rabbit syphilis has been previously assessed by lesion development following intradermal challenge with Treponema pallidum. We have recently reported that passive immunization using monoclonal antibody M131 conveys partial protection as evidenced by significant lesion delays following intradermal challenge. To determine whether such delays in time to lesion appearance corresponded to decreases in the numbers of spirochetes, we used real-time PCR to quantitate T. pallidum genomic DNA copy numbers in lesion biopsies taken throughout the course of lesion development. Three groups of animals were given one prechallenge passive immunization with immune rabbit serum (IRS), M131, or control monoclonal antibody (CMAb) and then challenged with treponemal admixtures of IRS or monoclonal antibody in normal rabbit serum (NRS). As compared to the CMAb NRS controls, delays in the mean time to lesion appearance of 5.8 days for IRS and 8.8 days for M131 were observed. At the earliest time point (10 days postchallenge), real-time PCR showed a mean T. pallidum DNA copy number per mug of rabbit DNA in the CMAb NRS group of 7.65 x 10(3) copies, while no T. pallidum DNA could be detected in the M131 group. At approximately the mean time to lesion appearance in the IRS and M131 groups (17 and 20 days, respectively), the numbers of T. pallidum DNA copies were still 5- and 30-fold less, respectively, than those in the control group at these times. By 30 days postchallenge, the T. pallidum DNA copy numbers were similar in all three groups. These findings indicate that the delays in appearance of syphilitic lesions conferred by IRS and M131 corresponded to a marked decrease in treponemal numbers during the course of lesion development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113312      PMCID: PMC1231113          DOI: 10.1128/IAI.73.9.5923-5927.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Membrane topology and cellular location of the Treponema pallidum glycerophosphodiester phosphodiesterase (GlpQ) ortholog.

Authors:  D V Shevchenko; T J Sellati; D L Cox; O V Shevchenko; E J Robinson; J D Radolf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  The tprK gene is heterogeneous among Treponema pallidum strains and has multiple alleles.

Authors:  A Centurion-Lara; C Godornes; C Castro; W C Van Voorhis; S A Lukehart
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Use of the skin protection assay in experimental syphilis to assess protective immunity against a specific Treponema pallidum surface epitope.

Authors:  David R Blanco; Cheryl I Champion; Michael A Lovett
Journal:  FEMS Microbiol Lett       Date:  2005-08-01       Impact factor: 2.742

4.  Multiple alleles of Treponema pallidum repeat gene D in Treponema pallidum isolates.

Authors:  A Centurion-Lara; E S Sun; L K Barrett; C Castro; S A Lukehart; W C Van Voorhis
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

5.  Effects of passive immunization on experimental syphilis in the rabbit.

Authors:  T B Turner; P H Hardy; B Newman; E E Nell
Journal:  Johns Hopkins Med J       Date:  1973-11

6.  Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model.

Authors:  Cecilia A Morgan; Sheila A Lukehart; Wesley C Van Voorhis
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum.

Authors:  David R Blanco; Cheryl I Champion; Alek Dooley; David L Cox; Julian P Whitelegge; Kym Faull; Michael A Lovett
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis.

Authors:  Johann Truccolo; Françoise Charavay; Fabrice Merien; Philippe Perolat
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92.

Authors:  C E Cameron; S A Lukehart; C Castro; B Molini; C Godornes; W C Van Voorhis
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

10.  The TprK protein of Treponema pallidum is periplasmic and is not a target of opsonic antibody or protective immunity.

Authors:  K R Hazlett; T J Sellati; T T Nguyen; D L Cox; M L Clawson; M J Caimano; J D Radolf
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  2 in total

Review 1.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

2.  Assessment of the kinetics of Treponema pallidum dissemination into blood and tissues in experimental syphilis by real-time quantitative PCR.

Authors:  Juan C Salazar; Asha Rathi; Nelson L Michael; Justin D Radolf; Linda L Jagodzinski
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.